iFAST Overview
- Year Founded
-
2022
- Status
-
Private
- Employees
-
30
- Latest Deal Type
-
Series A
- (Upcoming)
- Latest Deal Amount
-
$13.4M
- Investors
-
13
iFAST General Information
Description
Operator of a medical research company intended to reduce the threat of antimicrobial resistance. The company facilitates antimicrobial susceptibility test systems to avoid the growth of bacteria in the sample and determines the optimum antibiotic for clinicians to prescribe, enabling researchers to improve the outcomes.
Contact Information
Website
www.ifastdiagnostics.comCorporate Office
- Solent Business Park
- 1500 Parkway, Whitley
- Fareham PO15 7AF
- England, United Kingdom
Corporate Office
- Solent Business Park
- 1500 Parkway, Whitley
- Fareham PO15 7AF
- England, United Kingdom
iFAST Timeline
iFAST Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Early Stage VC (Series A) | 01-Jun-2027 | $13.4M | Upcoming | Generating Revenue | ||
| 6. Early Stage VC | 27-May-2026 | Completed | Generating Revenue/Not Profitable | |||
| 5. Seed Round | 05-Nov-2024 | Completed | Product Development | |||
| 4. Grant | 25-Aug-2023 | Completed | Generating Revenue | |||
| 3. Accelerator/Incubator | 16-Mar-2023 | Completed | Startup | |||
| 2. Seed Round | 23-Jan-2023 | $2.36M | $2.36M | Completed | Startup | |
| 1. University Spin-Out | 01-Apr-2022 | Completed | Startup |
iFAST Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| SEED PREFERRED | ||||||||
| SEED PREFERRED | ||||||||
| Ordinary | 104,994 | $0.000013 | $24.94 | $24.94 | 1x | $24.94 | 25.1% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
iFAST Signals
iFAST Investors (13)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Einkaufsbüro Deutscher Eisenhändler Gesellschaft Mit Beschränkter Haftung | Corporation | Minority | ||
| OKG Capital | Venture Capital | Minority | ||
| Raw Ventures | Venture Capital | Minority | ||
| SHIFT Ventures (London) | Venture Capital | Minority | ||
| INCATE | Accelerator/Incubator |
iFAST FAQs
-
When was iFAST founded?
iFAST was founded in 2022.
-
Where is iFAST headquartered?
iFAST is headquartered in Fareham, United Kingdom.
-
What is the size of iFAST?
iFAST has 30 total employees.
-
What industry is iFAST in?
iFAST’s primary industry is Biotechnology.
-
Is iFAST a private or public company?
iFAST is a Private company.
-
What is iFAST’s current revenue?
The current revenue for iFAST is .
-
How much funding has iFAST raised over time?
iFAST has raised $15.6M.
-
Who are iFAST’s investors?
Einkaufsbüro Deutscher Eisenhändler Gesellschaft Mit Beschränkter Haftung, OKG Capital, Raw Ventures, SHIFT Ventures (London), and INCATE are 5 of 13 investors who have invested in iFAST.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process